TRISTAR HENDERSONVILLE MEDICAL CENTE — History
CCN 440194 | 3-year financial timeline | COVID resilience: 56/100
🛡️ Public data only — no PHI permitted on this instance.
$209M
Latest Revenue (FY2022)
+2.0%
Revenue CAGR (3yr)
41.5%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $200M | $205M | $209M | +1.7% | +2.0% |
| Operating Expenses | $122M | $134M | $122M | -8.6% | +0.1% |
| Operating Margin | 39.2% | 34.9% | 41.5% | +18.9% | +2.8% |
| Net Income | $79M | $72M | $86M | +20.9% | +4.9% |
| Licensed Beds | 129 | 129 | 129 | +0.0% | +0.0% |
| Total Patient Days | 32,388 | 34,601 | 33,565 | -3.0% | +1.8% |
| Medicare Day % | 25% | 22% | 21% | -5.0% | -7.2% |
| Medicaid Day % | 7% | 5% | 6% | +6.5% | -6.3% |
COVID Impact & Recovery
Resilience Score: 56/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +4.1% ($200M → $209M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+2.0%
This Hospital
+7.6%
State Avg
Latest Margin
41.5%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $213M | 42.6% |
| FY2024 (proj) | $217M | 43.7% |
| FY2025 (proj) | $221M | 44.8% |